Cargando…

Dyslipidemia-associated atherogenic oxidized lipids induce platelet hyperactivity through phospholipase Cγ2-dependent reactive oxygen species generation

Oxidized low-density lipoprotein (oxLDL) and associated oxidized phosphocholine-headgroup phospholipids (oxPCs) activate blood platelets through ligation of the scavenger receptor CD36. Previously, we found that oxLDL stimulated phosphorylation of phospholipase Cγ2 (PLCγ2). However, the functional r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Berger, Martin, Wraith, Katie, Woodward, Casey, Aburima, Ahmed, Raslan, Zaher, Hindle, Matthew S., Moellmann, Julia, Febbraio, Maria, Naseem, Khalid M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2018
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6457275/ https://www.ncbi.nlm.nih.gov/pubmed/29733744 http://dx.doi.org/10.1080/09537104.2018.1466386

Ejemplares similares

Atherogenic lipid stress induces platelet hyperactivity through CD36-mediated hyposensitivity to prostacyclin: the role of phosphodiesterase 3A
por: Berger, Martin, et al.
Publicado: (2020)

The Spatiotemporal Regulation of cAMP Signaling in Blood Platelets—Old Friends and New Players
por: Raslan, Zaher, et al.
Publicado: (2015)

Acute Hypertriglyceridemia Induces Platelet Hyperactivity That is Not Attenuated by Insulin in Polycystic Ovary Syndrome
por: Aye, Myint Myint, et al.
Publicado: (2014)

Atherogenic dyslipidemia
por: Manjunath, C. N., et al.
Publicado: (2013)

Prostacyclin reverses platelet stress fibre formation causing platelet aggregate instability
por: Yusuf, M. Z., et al.
Publicado: (2017)

Oxidised Low-Density Lipoprotein-Induced Platelet Hyperactivity—Receptors and Signalling Mechanisms
por: Berger, Martin, et al.
Publicado: (2022)

Search for genetic factors predisposing to atherogenic dyslipidemia
por: Yip, Agustin G, et al.
Publicado: (2003)

Atherogenic Dyslipidemia: Cardiovascular Risk and Dietary Intervention
por: Musunuru, Kiran
Publicado: (2010)

Oxidative Stress, Atherogenic Dyslipidemia, and Cardiovascular Risk
por: Vekic, Jelena, et al.
Publicado: (2023)

Restoration of Responsiveness of Phospholipase Cγ2-Deficient Platelets by Enforced Expression of Phospholipase Cγ1
por: Zheng, Yongwei, et al.
Publicado: (2015)

Adipocyte Triglyceride Turnover Is Independently Associated With Atherogenic Dyslipidemia
por: Frayn, Keith, et al.
Publicado: (2012)

Atherogenic Dyslipidemia and Cardiovascular Risk Factors in Obese Children
por: D'Adamo, Ebe, et al.
Publicado: (2015)

Hibernating brown bears are protected against atherogenic dyslipidemia
por: Giroud, Sylvain, et al.
Publicado: (2021)

Alterations in Platelet Alpha-Granule Secretion and Adhesion on Collagen under Flow in Mice Lacking the Atypical Rho GTPase RhoBTB3
por: Berger, Martin, et al.
Publicado: (2019)

Atherogenic dyslipidemia and diabetes mellitus: what’s new in the management arena?
por: Kumar, Ajoy, et al.
Publicado: (2010)

Atherogenic Dyslipidemia in Children: Evaluation of Clinical, Biochemical and Genetic Aspects
por: Montali, Anna, et al.
Publicado: (2015)

Atherogenic Dyslipidemia and Residual Vascular Risk in Practice of Family Doctor
por: Alibasic, Esad, et al.
Publicado: (2015)

Glycative Stress, Glycated Hemoglobin, and Atherogenic Dyslipidemia in Patients with Hyperlipidemia
por: Yao, Chien-An, et al.
Publicado: (2023)

Prevalence of dyslipidemia, atherogenic and cardiovascular risk in overweight and obese adolescents
por: de Andrades, Clara dos Santos, et al.
Publicado: (2023)

Preanalytical conditions for multiparameter platelet flow cytometry
por: Hindle, Matthew S., et al.
Publicado: (2023)

The Association of Dyslipidemia and Atherogenic Indices With Glycemic Control in Diabetic Dyslipidemia Patients: A Real-World Landscape
por: Bage, Isaac J, et al.
Publicado: (2023)

Role of Glitazars in atherogenic dyslipidemia and diabetes: Two birds with one stone?
por: Munigoti, Srinivasa P., et al.
Publicado: (2014)

High Density Lipoprotein Particle Size in Children: Relation to Atherogenic Dyslipidemia
por: Numata, Michio
Publicado: (2004)

Correction: Atherogenic Dyslipidemia in Children: Evaluation of Clinical, Biochemical and Genetic Aspects
por: Montali, Anna, et al.
Publicado: (2015)

Pathogenesis of Insulin Resistance and Atherogenic Dyslipidemia in Nonalcoholic Fatty Liver Disease
por: Akhtar, Daud H., et al.
Publicado: (2019)

Low carbohydrate diets improve atherogenic dyslipidemia even in the absence of weight loss
por: Feinman, Richard D, et al.
Publicado: (2006)

Prevalence and Predictors of Atherogenic Serum Lipoprotein Dyslipidemia in Women with Obstructive Sleep Apnea
por: Xia, Yunyan, et al.
Publicado: (2017)

Cardiovascular risk profile of patients with atherogenic dyslipidemia in middle age Lithuanian population
por: Kutkiene, Sandra, et al.
Publicado: (2018)

Atherogenic Dyslipidemias: Unmet Needs and the Therapeutic Potential of Emerging and Novel Approaches and Drugs
por: Romandini, Alessandra, et al.
Publicado: (2023)

Association between Wakeup Frequency at Night and Atherogenic Dyslipidemia: Evidence for Sex Differences
por: Yao, Chien-An, et al.
Publicado: (2023)

Atherogenic dyslipidemia in metabolic syndrome and type 2 diabetes: therapeutic options beyond statins
por: Tenenbaum, Alexander, et al.
Publicado: (2006)

Association of Serum Retinol Binding Protein 4 with Atherogenic Dyslipidemia in Morbid Obese Patients
por: Rocha, Milagros, et al.
Publicado: (2013)

High-Risk Atherosclerosis and Metabolic Phenotype: The Roles of Ectopic Adiposity, Atherogenic Dyslipidemia, and Inflammation
por: Lechner, Katharina, et al.
Publicado: (2020)

Association of CETP Gene Variants with Atherogenic Dyslipidemia Among Thai Patients Treated with Statin
por: Srisawasdi, Pornpen, et al.
Publicado: (2021)

Angiopoietin-like proteins inhibitors: New horizons in the treatment of atherogenic dyslipidemia and familial hypercholesterolemia
por: Surma, Stanisław, et al.
Publicado: (2023)

Prospects of potential adipokines as therapeutic agents in obesity-linked atherogenic dyslipidemia and insulin resistance
por: Roy, Probin Kr, et al.
Publicado: (2023)

Current Data and New Insights into the Genetic Factors of Atherogenic Dyslipidemia Associated with Metabolic Syndrome
por: Butnariu, Lăcramioara Ionela, et al.
Publicado: (2023)

Genetic Disruption of Myostatin Reduces the Development of Proatherogenic Dyslipidemia and Atherogenic Lesions In Ldlr Null Mice
por: Tu, Powen, et al.
Publicado: (2009)

Plasma vitamin D and parathormone are associated with obesity and atherogenic dyslipidemia: a cross-sectional study
por: Guasch, Alba, et al.
Publicado: (2012)

Correction: Association of Serum Retinol Binding Protein 4 with Atherogenic Dyslipidemia in Morbid Obese Patients
por: Rocha, Milagros, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_1u3qstddosg4qr3iced28tpvr4